Supplementary Material for: Tobacco Cessation in Oncology Care

Globally, tobacco use is a major modifiable risk factor and leading cause of many forms of cancer and cancer death. Tobacco use contributes to poorer prognosis in cancer care. This article reviews the current state of tobacco cessation treatment in oncology. Effective behavioral and pharmacological treatments exist for tobacco cessation, but are not being widely used in oncology treatment settings. Comprehensive tobacco treatment increases success with quitting smoking and can improve oncological and overall health outcomes. This article describes the components of a model treatment program, which includes automatic referrals for all current tobacco users and recent quitters, motivational interviewing during initial and follow-up contacts, combined behavioral and pharmacological interventions for cessation, and systematic follow-up phone calls for relapse prevention.

在全球范围内，烟草使用是一类主要的可改变危险因素（modifiable risk factor），同时也是多种癌症及癌症相关死亡的首要诱因。烟草使用会恶化癌症患者的诊疗预后。本文综述了肿瘤学（oncology）领域烟草戒断（tobacco cessation）治疗的当前现状。目前已有成熟的行为干预与药物治疗手段可用于烟草戒断，但在肿瘤临床诊疗场景中并未得到广泛应用。全面的烟草干预方案可提升戒烟成功率，并改善肿瘤患者的肿瘤学结局与整体健康水平。本文阐述了标准化治疗方案的核心组成要素，具体包括为所有当前烟草使用者及近期戒烟者提供自动转诊服务、在初次与随访接触中开展动机访谈（motivational interviewing）、联合采用行为干预与药物干预手段实施戒断治疗，以及通过系统化电话随访开展复发预防（relapse prevention）。